BioSpace News Archive

Business

ADC Therapeutics and Adagene Team Up to Develop Anti-Cancer Molecules

ADC Therapeutics, based in Lausanne, Switzerland, and Adagene, headquartered in Suzhou, China and San Francisco, announced a discovery collaboration and license deal.

April 24, 2019
·
2 min read
·
Mark Terry
Business

ADC Therapeutics and Adagene Announce License Agreement

ADC Therapeutics to develop next-generation masked antibody drug conjugates (ADCs), incorporating Adagene’s SAFEbody™ technology, with potential utility across multiple tumor types

April 24, 2019
·
4 min read
Thiazide diuretics reduced the risk of fractures in people with Alzheimer’s disease

The use of thiazide diuretics was associated with a decreased risk of low energy fractures in people with Alzheimer’s disease, a new study from the University of Eastern Finland shows.

April 24, 2019
·
1 min read
Business

CDMO Yposkesi appoints new Director of Viral Vector Manufacturing Operations

With 15 years’ bioproduction and cell & gene therapy expertise, Morad El Gueddari will take charge of Yposkesi’s industrial-scale viral vector manufacturing

April 24, 2019
·
2 min read
Cytura Therapeutics to Develop a New Class of Drugs Targeting genomic instability in cancer

Cytura Therapeutics announces the successful closure of a Seed financing round.

April 24, 2019
·
3 min read
Yposkesi chairman Dr. Frederic Revah to speak on ‘Manufacturing and the CDMO Perspective’

Dr. Revah will join fellow industry panelists at the Cell and Gene Meeting on the Med in Barcelona to discuss strategies for gene therapy manufacturing, on April 23rd

April 24, 2019
·
2 min read
Policy

Government Files Criminal Charges Against Opioid Distributor and Two Former Executives

The government said the executives and the company failed to comply with its legal obligation to report thousands of suspicious orders of controlled substances to the DEA.

April 24, 2019
·
3 min read
·
Alex Keown
Drug Development

Researchers Provide More Evidence That a Blood Test Can Detect the Risk of Alzheimer’s

Researchers at Sweden’s Lund University reported that a blood test can reveal whether there is accelerating nerve cell damage in the brain.

April 24, 2019
·
3 min read
·
Alex Keown
Eisai Selected as Competitive ICT Strategy Company for 2019

Recognized for Taking on Challenge of Transformation to New Business Models by Integrating Management and Ict Strategies

April 24, 2019
·
2 min read
Policy

Under Fire, Biopharma Increases Lobbying Expenses to Influence Opinion and Legislation

One of the criticisms of the biopharma industry—at least in the context of drug pricing—is how much the industry as a whole spends on lobbyists. For example, last year, PhRMA, the industry lobbying group, spent more than $27.5 million on its lobbying activities.

April 24, 2019
·
4 min read
·
Mark Terry